ÂÜÀòÂÒÂ×

Caroline Popper M.D. MPH co-founded Popper and Company in 2003 and serves as the President. The company focuses on improving the efficiency of the healthcare system by leveraging technology and new biological insights. Caroline has also held advisory board and board member positions at various organizations such as Johns Hopkins Bloomberg School of Public Health, Avance Clinical, Riverside Partners, Agilex Biolabs Pty Ltd, LBT Innovations (Australia), and BioAgilytix. Caroline has served as an advisor for Johns Hopkins inHealth Precision Medicine and was the Chairman and CEO of Diversigen, Inc. from 2015 to 2019. Additionally, Caroline has acted as an external advisor for the Innovation Fellows Program at the US Department of Health and Human Services from 2014 to 2017.

Caroline Popper pursued their education in a chronological manner, beginning with their enrollment at the University of the Witwatersrand from 1977 to 1983. During this period, they obtained their MBBCh degree, although the specific field of study is unknown. Caroline continued their education at The Johns Hopkins University, where they completed their Master of Public Health (MPH) degree in Health Policy and Health Economics from 1989 to 1990. Following this, they obtained the Robert Wood Johnson Fellowship in Healthcare Finance for the year 1990-1991. Although the degree or field of study associated with this fellowship is not mentioned.